The Centers for Medicare and Medicaid Cervices (CMS) posted information encouraging pharmacies and other affected parties to prepare now for the expected transition of coverage, from Medicare Part D to Medicare Part B, for Pre-exposure Prophylaxis (PrEP) antiretroviral drugs to prevent HIV.
The final National Coverage Determination (NCD) is expected to be released in late September 2024, and coverage under Part B will begin once CMS releases the final NCD. Information about this coverage transition can be found at: PrEP for HIV & Related Preventive Services.
